Logo
Whalesbook
HomeNewsCorporate NewsPremiumStocks
HomeNewsCorporate NewsPremiumStocks

National Oxygen Ltd

₹ 88.1-1.39%
16 Jan 4:01 p.m. – close price
🔗nolgroup.com•BSE: 507813•NSE:
Market Cap₹ 44.4 Cr.
Current Price₹ 88.1
High / Low₹ 147
Stock P/Enull
Book Value₹ -5.63
Dividend Yield0.00 %
ROCE-21.5 %
ROEnull %
Face Value₹ 10.0
Sales₹ 33.4 Cr.
OPM-12.0 %
Mar Cap₹ 44.4 Cr.

ABOUT

Incorporated in 1974, National Oxygen Ltd is a manufacturer and supplier of IndustrialGases both in Liquid and Gaseous form[1]

KEY POINTS

Product Profile:[1]a) High Pure Liquid Oxygenb) High Pure Gaseous Oxygenc) High Pure Liquid Nitrogend) Medical Grade Oxygen Liquide) Medical Grade Oxygen Gasf) High Purity Nitrogen Gasg) Dissolved Acetylene Gas

Also present in buckets:
Red Flags And Poor Performance

Peer Comparision

S.No.NameCurrent Price (Rs.)Price to EarningMarket Capitalization (Rs.Cr.)Dividend yield (%)Net Profit latest quarter (Rs.Cr.)YOY Quarterly profit growth (%)Sales latest quarter (Rs.Cr.)YOY Quarterly sales growth (%)Return on capital employed (%)Sales (Rs.Cr.)OPM (%)Profit after tax (Rs.Cr.)Profit after tax latest quarter (Rs.Cr.)Price to book valueReturn on assets (%)Debt to equity
1.Linde India6107.00103.1052167.580.07169.0161.90644.191.5416.902413.0136.53505.97169.0113.188.990.02
2.Ellen.Indl.Gas268.9543.423790.460.0036.7223.8489.17-5.8518.23312.4835.1580.2236.724.1110.570.13
3.Refex Industries238.4018.643266.400.2136.1941.07426.85-0.2720.892136.5110.44175.3046.542.4412.190.14
4.Stallion India215.5038.101708.590.0011.421243.53105.5656.2519.67452.7513.9044.8411.425.3812.120.00
5.Hilltone Softwar61.85–67.610.00-0.71-745.453.4565.072.349.21-13.79-1.26-0.714.58-0.960.03
6.Natl. Oxygen88.10–44.420.007.049.246.37-39.96-21.5433.35-12.05-7.52-1.08–-21.51–
7.Gagan Gases21.9182.509.900.00-0.01-112.501.6515.3810.645.423.690.12-0.013.067.160.12
–Median: 4 Co.253.6840.763528.430.0436.4551.48266.210.6418.951294.6324.52127.7641.634.7511.340.07

Quarterly Results

Standalone figures in ₹ crores

Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Sales
11.7411.9212.1011.1211.8111.3011.0210.5710.6110.788.627.586.37
Expenses
11.5711.3510.3710.5911.3111.3210.7910.5710.5511.5410.408.616.82
Operating Profit
0.170.571.730.530.50-0.020.230.000.06-0.76-1.78-1.03-0.45
Other Income
0.040.200.270.060.120.060.260.060.080.070.070.058.37
Profit before tax
-1.17-0.490.84-0.58-0.61-1.21-0.84-1.24-1.19-1.98-2.60-1.877.04
Tax %
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit
-1.17-0.480.84-0.58-0.60-1.21-0.84-1.25-1.19-1.98-2.59-1.877.04
EPS in Rs
-2.44-1.001.75-1.21-1.25-2.52-1.67-2.48-2.36-3.93-5.14-3.7113.96

Profit & Loss

Standalone Figures in ₹ Crores / Yearly

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales
25.8028.1333.1736.0941.3646.2143.9339.7650.6147.1145.2640.5833.35
Expenses
26.0829.5830.3631.4935.7437.6337.5433.4939.1843.4344.0243.0537.37
Operating Profit
-0.28-1.452.814.605.628.586.396.2711.433.681.24-2.47-4.02
Other Income
0.100.110.350.332.193.420.270.401.440.590.500.288.56
Interest
3.575.436.106.465.904.904.804.482.151.791.641.591.28
Depreciation
3.864.173.943.913.793.533.413.283.093.273.333.222.67
Profit before tax
-7.61-10.94-6.88-5.44-1.883.57-1.55-1.097.63-0.79-3.23-7.000.59
Net Profit
-5.26-10.83-5.68-5.41-1.873.56-1.57-1.107.63-0.79-3.23-7.000.60
EPS in Rs
-10.95-22.55-11.83-11.27-3.897.41-3.27-2.2915.89-1.65-6.41-13.881.18
Dividend Payout %
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%–

Compounded Sales Growth

10 Years:4%
5 Years:-2%
3 Years:-7%
TTM:-23%

Compounded Profit Growth

10 Years:3%
5 Years:%
3 Years:%
TTM:-67%

Stock Price CAGR

10 Years:6%
5 Years:15%
3 Years:-16%
1 Year:-28%

Return on Equity

10 Years:%
5 Years:%
3 Years:%
Last Year:%

Balance Sheet

Standalone figures in ₹ crores

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
4.804.804.804.804.804.804.804.804.804.805.045.045.04
Reserves
12.751.34-4.35-11.45-13.31-9.74-11.34-12.41-4.79-5.73-6.04-13.05-7.88
Borrowings
37.5243.3348.4049.0144.0638.0938.6037.2132.8229.0628.6530.6925.28
Other Liabilities
7.477.887.006.746.376.046.166.396.976.786.458.417.61
Total Liabilities
62.5457.3555.8549.1041.9239.1938.2235.9939.8034.9134.1031.0930.05
Fixed Assets
52.6148.7744.8839.8135.2431.9129.0126.4824.2722.0721.9819.5818.49
Gross Block
76.2077.2777.2976.9766.4566.2366.5267.2764.1165.1868.4269.24–
Accumulated Depreciation
23.5928.5032.4137.1631.2134.3237.5140.7939.8443.1046.4449.66–
CWIP
0.000.000.000.030.030.030.030.060.000.140.810.183.45
Investments
0.770.560.160.010.110.170.190.210.100.050.080.330.33
Other Assets
9.168.0210.819.256.547.088.999.2415.4312.6511.2311.007.78
Total Assets
62.5457.3555.8549.1041.9239.1938.2235.9939.8034.9134.1031.0930.05

Cash Flows

Standalone Figures in ₹ Crores / Yearly

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity
-2.371.301.494.878.457.854.836.5311.592.230.97-0.18
Cash from Investing Activity
-4.36-1.67-0.450.712.683.12-0.39-0.700.40-0.62-3.69-0.21
Cash from Financing Activity
6.770.39-1.03-5.85-10.86-10.86-4.30-5.87-6.54-5.931.070.45
Net Cash Flow
0.040.020.01-0.270.280.110.14-0.045.46-4.32-1.660.07

Ratios

Standalone Figures in ₹ Crores / Yearly

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days
62.5346.7166.4645.4132.9233.3340.7145.9036.3541.3742.7429.32
Inventory Days
––––––––––––
Days Payable
––––––––––––
Cash Conversion Cycle
62.5346.7166.4645.4132.9233.3340.7145.9036.3541.3742.7429.32
Working Capital Days
-116.01-159.34-98.38-99.21-82.34-50.24-27.83-29.382.4511.47-17.02-45.33
ROCE %
-7.83%-10.43%-1.67%2.15%5.44%15.05%9.85%10.90%27.81%3.28%-5.88%-21.54%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Promoters
69.99%69.99%69.99%69.99%69.99%69.99%71.42%71.29%71.29%71.29%71.29%71.24%
FIIs
––––––––––––
DIIs
––––––––––––
Public
30.00%30.00%30.01%30.01%30.01%30.01%28.59%28.72%28.72%28.71%28.72%28.77%

* The classifications might have changed from Sep'2022 onwards.ℹ️

BSE Announcements AI Summary

Direct from BSE filings, auto-summarised

National Oxygen Limited to Close Trading Window from April 1, 2026, for Financial Results

27th March 2026, 12:03 am

National Oxygen Board Approves Preferential Issue of Equity Shares to Promoter Group

20th March 2026, 11:30 pm

National Oxygen Board Approves Preferential Issue of Equity Shares to Promoter Group

20th March 2026, 11:23 pm

National Oxygen Limited to consider preferential share issue at March 20 Board Meeting

17th March 2026, 11:42 pm

Madras High Court Allows TANGEDCO Appeals, Dismisses Writ Petitions on Demand Charges

10th February 2026, 9:45 pm

Published by Other Websites

External media mentions & references

National Oxygen Board to Meet March 20 for Preferential Issue
National Oxygen Approves Preferential Issue of 9.5 Lakh Shares to Promoter
National Oxygen Board Approves Preferential Issue to Promoter Entity
National Oxygen Closes Trading Window for Audited FY26 Results

Documents

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

12 Jan - Registrar confirmation under SEBI Reg 74(5) for quarter ended 31 Dec 2025.

Closure of Trading Window
Announcement under Regulation 30 (LODR)-Newspaper Publication

20 Nov 2025 - Newspaper Publication for the quarter ended 30.09.2025

Non Applicability Certificate Of Regulation 23(9) Of SEBI(LODR)2015

12 Nov 2025 - Regulation 23(9) not applicable; paid-up capital Rs5.04 crore, net worth -Rs8.00 crore (as of 31 Mar 2025).

Financial Results For The Quarter Ended 31St March 2025

12 Nov 2025 - Board approved unaudited Q2/H1 results for Sep 30, 2025; exceptional land sale profit Rs.812.26 lakh.

Annual Reports

Financial Year 2025

(from bse)

Financial Year 2024

(from bse)

Financial Year 2023

(from bse)

Financial Year 2022

(from bse)

Financial Year 2021

(from bse)

Financial Year 2020

(from bse)

Financial Year 2019

(from bse)

Financial Year 2018

(from bse)

Financial Year 2017

(from bse)

Financial Year 2016

(from bse)

Financial Year 2015

(from bse)

Financial Year 2014

(from bse)

Financial Year 2013

(from bse)

Financial Year 2012

(from bse)

Financial Year 2011

(from bse)

Credit Ratings

Rating update

16 Sep 2025 from smera

Rating update

18 Jun 2024 from smera

Rating update

23 Mar 2023 from smera

Rating update

30 Dec 2021 from smera

Rating update

6 Oct 2020 from smera

Rating update

15 Jul 2019 from smera

Concalls

No concalls.

Stock Analysis

Description

National Oxygen Limited is an Indian company engaged in the manufacturing and supply of industrial and medical gases. The company has faced significant financial and operational challenges recently.

Key Growth Triggers

Currently no data available for Key Growth Triggers.

Order Book

Currently no data available for Order Book.

Key Red Flags

Persistent financial losses, negative equity, revenue declines, and reliance on asset sales for debt servicing are significant concerns identified from past financial reporting and company data. Operational issues have also impacted performance.

Key Dates To Watch

The upcoming announcement of Q3 FY26 financial results, which would follow this regulatory filing, is of importance for assessing the company's recent performance.

Corporate Announcements

26th Mar 26
Impact Rating: 6
National Oxygen Limited has informed exchanges that its trading window will be closed from April 1, 2026, until 48 hours after the declaration of its audited financial results for the quarter and year ending March 31, 2026.
20th Mar 26
Impact Rating: 7
National Oxygen Limited's Board of Directors greenlit a preferential issue of up to 9,50,000 equity shares with a face value of ₹10 each, to Saraf Housing Development Private Limited, a promoter group entity.
20th Mar 26
Impact Rating: 6
National Oxygen Limited's Board of Directors has approved the issuance of up to 9,50,000 equity shares at a face value of Rs. 10 each, on a preferential basis to Saraf Housing Development Private Limited.
17th Mar 26
Impact Rating: 7
National Oxygen Limited announced a Board Meeting on March 20, 2026, to evaluate a proposal for a preferential issue of up to 8,50,000 equity shares, a move for fundraising.
10th Feb 26
Impact Rating: 4
TANGEDCO wins legal battle as Madras High Court allows appeals, quashing lower court order on demand charges.